TOKYO, June 27 (Reuters) - Japanese technology investor
SoftBank Group 9984.T has launched a joint venture with Tempus
AI TEM.O that aims to analyse personal medical data with
artificial intelligence (AI) to come up with treatment
recommendations.
This is the latest in a string of AI investments SoftBank
has recently announced as it increases the pace of its
investment activity after a muted few years.
SoftBank invested around $200 million in Tempus in its
series G funding round in April before Tempus listed on the
Nasdaq in May.
($1 = 160.4700 yen)
(Reporting by Anton Bridge; Editing by Christopher Cushing and
Miral Fahmy)
((Anton.Bridge@thomsonreuters.com;))